Magazine article from our research archive:

Acomplia linked to deaths since approval in U.K.

Sanofi-Aventis' Acomplia weight-loss treatment, rejected last June by a panel of FDA experts, was linked to five deaths in the U.K. since the medicine went on sale two years ago, Bloomberg reported June 3.

There were 720 reports of adverse drug reactions mentioned from use of Acomplia in the U.K., the London-based Medicines and Healthcare Products Regulatory Agency (MHRA) said. Some of the ADRs involved more than one side effect, bringing the total to more than 2,100, Sanofi said. The data, covering reports from the June 2006 introduction to May 9, was released on its Web site.

Five of the cases were fatal, including one patient who committed suicide, according to the ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!